The END Fund
The END Fund
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for The END Fund? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
To control and eliminate the most prevalent neglected diseases.
About
The END Fund mobilizes resources for neglected tropical diseases, and focuses on delivering neglected tropical disease (NTD) treatments to those in need by growing and engaging a community of activist-philanthropists, managing high-impact strategic investments, and working in collaboration with government, NGO, pharmaceutical, and academic partners. We aim to take a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending NTDs.
Interesting data from their 2020 990 filing
The non-profit's mission, as described in the filing, is “The end fund focuses on delivering neglected tropical disease (ntd) treatments to those in need by growing and engaging a community of activist-philanthropists, managing high-impact strategic investments, and working in collaboration with government, ngo, pharmaceutical, and academic partners. we aim to take a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending ntds.”.
When describing its duties, they were characterized as: “The end fund's mission is to control and eliminate the most prevalent neglected tropical diseases (ntd's) among the world's poorest and most vulnerable people.”.
- The non-profit has complied with legal regulations by reporting their state of operation as DE.
- The filing shows that the non-profit's address as of 2020 is 2 Park Avenue 18th Floor, New York, NY, 10016.
- As of 2020, the non-profit has reported a total of 44 employees on their form.
- Does not operate a hospital.
- Does not operate a school.
- Does not collect art.
- Does not provide credit counseling.
- Has foreign activities.
- Is not a donor-advised fund.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $13,967,146.
- The compensation of the CEO of the organization is subject to review and approval by an independent body.
- The organization has a written policy that describes how long it will retain documents.
- The organization has a foreign financial account.
- The organization has 6 independent voting members.
- The organization was formed in 2010.
- The organization has a written policy that addresses conflicts of interest.
- The organization is required to file Schedule B.
- The organization is required to file Schedule J.
- The organization is required to file Schedule O.
- The organization pays $5,003,110 in salary, compensation, and benefits to its employees.
- The organization pays $1,483,735 in fundraising expenses.
- The organization provides Form 990 to its governing body.
- The organization has minutes of its meetings.
- The organization has a written whistleblower policy.
- The organization has grants to organizations.
- The organization's financial statements were reviewed by an accountant.